Orqis(R) Medical’s Cancion(R) System Significantly Increases Cardiac Performance

Orqis(R) Medical Corporation, a medical products company developing and marketing devices to treat heart failure, announced that the company’s MOMENTUM Trial results were presented during the Late Breaking Clinical Trials session at the annual American College of Cardiology (ACC) meeting in Chicago. The MOMENTUM Trial evaluated the percutaneous Cancion System in patients hospitalized with heart failure. Barry Greenberg, M.D.

More: continued here

Filed under: Cardiovascular on April 2nd, 2008